# Ariad Pharmaceuticals

**Type:** Funders  
**Canonical URL:** https://scholariq.org/funders/ariad-pharmaceuticals/

## Facts

| Field | Value |
| --- | --- |
| Country | US |
| Description | defunct oncology company |
| OpenAlex ID | https://openalex.org/F4320309021 |
| ROR ID | https://ror.org/01dwtyk53 |
| Works | 1,005 |

## Funder papers

- [<i>EGFR</i> -Mutant Adenocarcinomas That Transform to Small-Cell Lung Cancer and Other Neuroendocrine Carcinomas: Clinical Outcomes](https://scholariq.org/papers/i-egfr-i-mutant-adenocarcinomas-that-transform-to-small-cell-lung-cancer-and/)
- [Small cell transformation in EGFR-mutated non-small cell lung cancer: DLL3 expression and efficacy of immune checkpoint inhibitors or tyrosine kinase inhibitors combined with chemotherapy](https://scholariq.org/papers/small-cell-transformation-in-egfr-mutated-non-small-cell-lung-cancer-dll3/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.